0000950170-23-070888.txt : 20231215 0000950170-23-070888.hdr.sgml : 20231215 20231215190408 ACCESSION NUMBER: 0000950170-23-070888 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230518 FILED AS OF DATE: 20231215 DATE AS OF CHANGE: 20231215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EGLINTON MANNER CARRIE CENTRAL INDEX KEY: 0001696776 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 231491868 MAIL ADDRESS: STREET 1: C/O QUEST DIAGNOSTICS STREET 2: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 4/A 1 ownership.xml 4/A X0508 4/A 2023-05-18 2023-05-22 0000730272 REPLIGEN CORP RGEN 0001696776 EGLINTON MANNER CARRIE C/O REPLIGEN CORPORATION 41 SEYON ST., BLDG 1, STE 100 WALTHAM MA 02453 true false false false false Common Stock 2792 D This Form 4/A amends a Form 4 filed on 5/22/2023 to correct an administrative error, which misreported the number of shares beneficially owned by the reporting person. The correction reflects an increase in the number of shares beneficially owned by the reporting person by 625 shares. /s/ Kimberly Brown (Attorney in Fact) 2023-12-15